New Position Statement Reaffirms American College of Endocrinology/ American Association of Clinical Endocrinologists Definition of Insulin Resistance Syndrome

Summary

---

JACKSONVILLE, Fla., Oct. 14 /U.S. Newswire/ -- Recently, several medical organizations have published statements reflecting changes in their definitions and assessment of "Metabolic Syndrome" (MS). Because of concern that these statements would create uncertainty and controversy among physicians and further confuse the general public, the American College of Endocrinology (ACE) and American Association of Clinical Endocrinologists (AACE) empowered a rapid response team to assess these statements and review their position in the new ACE and AACE: Reaffirmation of the 2003 ACE Insulin Resistance Syndrome (IRS) Position Statement.

According to the 2003 ACE Position Statement, IRS describes the cluster of abnormalities that are more likely to occur in insulin resistant/hyperinsulinemic individuals. The statement goes on to explain the label "metabolic syndrome" relies on an unclear definition of "metabolic" and is likely to become even less appropriate as the abnormalities associated with insulin resistance and compensatory hyperinsulinemia continue to be elucidated.

See the full content of this document

Extract

---

New Position Statement Reaffirms American College of Endocrinology/ American Association of Clinical Endocrinologists Definition of Insulin Resistance Syndrome

People with resistance to the actions of insulin have an increased risk of diabetes and cardiovascular disease, as well as polycystic ovary syn...

See the full content of this document

---